Kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering

Biotechnology and Bioengineering

Volumn 88, Issue 7, 2004, Pages 890-900

  Kurnaz, Isil Aksan ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Chromatin; GEPASI; HAT; RSK2; Transcription kinetics

Indexed keywords

BINDING ENERGY; CELLS; CHEMICAL ACTIVATION; COMPUTER SIMULATION; ENZYME INHIBITION; PROTEINS;

CELLULAR ENGINEERING; KINETIC ANALYSIS; MITOGENIC ACTIVATION; SERUM RESPONSE ELEMENT (SRE);

GENETIC ENGINEERING;

HISTONE ACETYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTAMINE KINASE; RIBOSOMAL S6 KINASE; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ARTICLE; BIOENGINEERING; CELLULAR ENGINEERING; CHEMICAL ANALYSIS; CHROMATIN; COFFIN LOWRY SYNDROME; COMPUTER PROGRAM; COMPUTER SIMULATION; ENZYME ACTIVATION; GENE; GENE ACTIVATION; GENE MUTATION; KINETICS; MITOGENESIS; NEUROLOGIC DISEASE; ONCOGENE C FOS; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RSK2 GENE; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ACETYLTRANSFERASES; CHROMATIN; COMPUTER SIMULATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HISTONE ACETYLTRANSFERASES; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SERUM RESPONSE ELEMENT; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

CERVUS ELAPHUS; MAMMALIA;

EID: 10844229390     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20322     Document Type: Article

References (68)

1. Aksan I, Kurnaz ML. 2003. A computer-based model for the regulation of mitogen activated protein kinase (MAPK) activation. J Recept Signal Transduct Res 23:197-209.
2. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
3. Bannister AJ, Miska EA, Gorlich D, Kouzarides T. 2000. Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr Biol 10:467-470.
4. Bhatt RR, Ferrell JE Jr. 2000. Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs. J Biol Chem 275:32983-32990.
5. Bruning JC, Gillette JA, Zhao Y, Bjorbaeck C, Kotzka J, Knebel B, Avci H, Hanstein B, Lingohr P, Moller DE, Krone W, Kahn CR, Muller-Wieland DR. 2000. Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc Natl Acad Sci U S A 97:2462-2467.
6. Chen RH, Sarnecki C, Blenis J. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 12:915-927.
7. Cheung. P, Allis CD, Sassone-Corsi P. 2000a. Signaling to chromatin through histone modifications. Cell 103:263-271.
8. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. 2000b. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5:905-915.
9. Chrestensen CA, Sturgill TW. 2002, Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase. J Biol Chem 277:27733-27741.
10. Clayton AL, Rose S, Barratt MJ, Mahadevan LC. 2000. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J 19:3714-3726.
11. Cowley DO, Graves BJ. 2000. Phosphorylation represses Ets-1 binding by reinforcing autoinhibition. Genes Dev 14:366-376.
12. Cruzalegui FH, Cano E, Treisman R. 1999. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 18:7948-7957.
13. Davis S, Vanhoutte P, Pages C, Caboche P, Laroche S. 2000. The MAPK/ ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 20:4563-4572.
14. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P. 1998. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A 95:12202-12207.
15. Delaunoy J, Abidi F, Zeniou M, Jacquot S, Merienne K, Pannetier S, Schmitt M, Schwartz C, Hanauer A. 2001. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Hum Mutat 17:103-116.
16. Fantz DA, Jacobs D, Glossip D, Kornfeld K. 2001. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J Biol Chem 276:27256-27265.
17. Forrest D, Curran T. 1992. Crossed signals: oncogenic transcription factors. Curr Opin Genet Dev 2:19-27.
18. Frodin M, Jensen CJ, Merienne K, Gammeltoft S. 2000. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 19:2924-2934.
19. Gullick WJ, Downward DJ, Marsden JJ, Waterfield MD. 1984. A radioimmunoassay for human epidermal growth factor receptor. Anal Biochem 141:253-261.
20. Haigler H, Ash JF, Singer SJ, Cohen S. 1978. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci U S A 75:3317-3321.
21. Hanlon M, Sturgill TW, Sealy L. 2001. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J Biol Chem 276:38449-38456.
22. Herrera RE, Shaw PE, Nordheim A. 1989. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340:68-70.
23. Hindmarsh AC. 1983. ODEPACK, a systematised collection of ODE solvers. In: Stepleman RS, et al. editors. Scientific computing. Amsterdam: North-Holland, p 55-64.
24. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, Cuellar AA, Dronov S, Gilles ED, Ginkel M, Gor V, Goryanin II, Hedley WJ, Hodgman TC, Hofmeyr JH, Hunter PJ, Juty NS, Kasberger JL, Kremling A, Kummer U, Le Novere N, Loew LM, Lucio D, Mendes P, Minch E, Mjolsness ED, Nakayama Y, Nelson MR, Nielsen PF, Sakurada T, Schaff JC, Shapiro BE, Shimizu TS, Spence HD, Stelling J, Takahashi K, Tomita M, Wagner J, Wang J. SBML Forum. 2003. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19:524-531.
25. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K. 1999. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13:163-175.
26. Janknecht R, Nordheim A. 1996a. Regulation of the c-fos promoter by the ternary complex factor Sap-la and its coactivator CBP. Oncogene 12:1961-1969.
27. Janknecht R, Nordheim A. 1996b. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun 228:831-837.
28. Johnson CA, White DA, Lavender JS, O'Neill LP, Turner BM. 2002. Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. J Biol Chem 277:9590-9597.
29. Krieger DE, Levine R, Merrifield RB, Vidali G, Allfrey VG. 1974. Chemical studies of histone acetylation: Substrate specificity of a histone deacetylase from calf thymus nuclei. J Biol Chem 249:332-334.
30. Levresse V, Butterfield L, Zentrich E, Heasley LE. 2000. Akt negatively regulates the cJun N-terminal kinase pathway in PC 12 cells. J Neurosci Res 62:799-808.
31. Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M. 2003. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J 22:281-291.
32. Ling Y, West AG, Roberts EC, Lakey JH, Sharrocks AD. 1998. Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface. J Biol Chem 273:10506-10514.
33. Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, Marmorstein R, Berger SL. 2000. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell 5:917-926.
34. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
35. Mendes P. 1993. GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems. Comput Appl Biosci 9:563-571.
36. Mendes P. 1997. Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22:361-363.
37. Mendes P, Kell D. 1997. Making cells work-metabolic engineering for everyone. Trends Biotechnol 15:6-7.
38. Mendes P, Kell D. 1998. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 14:869-883.
39. Mendes P, Kell DB. 2001. MEG (model extender for Gepasi): a program for the modelling of complex, heterogeneous, cellular systems. Bioinformatics 17:288-289.
40. Merienne K, Jacquot S, Zeniou M, Pannetier S, Sassone-Corsi P, Hanauer A. 2000. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway. Oncogene 19:4221-4229.
41. Merienne K, Pannetier S, Harel-Bellan A, Sassone-Corsi P. 2001. Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol Cell Biol 21:7089-7096.
42. Nissen L, Gelly J-C, Hipskind RA. 2001. Induction -independent recruitment of CREB-binding protein to the c-fos serum response element through interactions between the bromodomain and Elk-1. J Biol Chem 276:5213-5221.
43. Parker PJ, Young S, Gullick WJ, Mayes EL, Bennett P, Waterfield MD. 1984. Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells: Isolation, characterization, and use in the purification of active epidermal growth factor receptor. J Biol Chem 259:9906-9912.
44. Petzold LR. 1983. Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations. SIAM J Sci Stat Comput 4:36-148.
45. Polesskaya A, Naguibneva I, Fritsch L, Duquet A, Ait-Si-Ali S, Robin P, Vervisch A, Pritchard LL, Cole P, Harel-Bellan A. 2001. CBP/p300 and muscle differentiation: no HAT no muscle. EMBO J 20:6816-6825.
46. Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH. 1998. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8:1141-1150.
47. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD. 1999. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285:886-891.
48. Sharrocks AD. 2001. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2:827-837.
49. Sharrocks AD, Yang SH, Galanis A. 2000. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem Sci 25:48-453.
50. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW. 1999. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893-2898.
51. Smith JA, Poteet-Smith CE, Lannigan DA, Freed TA, Zoltoski AJ, Sturgill TW. 2000. Creation of a stress-activated p90 ribosomal S6 kinase. The carboxyl-terminal tail of the MAPK-activated protein kinases dictates the signal transduction pathway in which they function. J Biol Chem 275:31588-31593.
52. Tanner KG, Langer MR, Denu JM. 2000a. Kinetic mechanism of human histone acetyltransferase P/CAF. Biochemistry 39:11961-11969.
53. Tanner KG, Langer MR, Kim Y, Denu JM. 2000b. Kinetic mechanism of the histone acetyltransferase GCN5 from yeast. J Biol Chem 275:22048-22055.
54. Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC. 1999. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 18:4779-4793.
55. Tomas-Zuber M, Mary JL, Lamour F, Bur D, Lesslauer W. 2001. C-terminal elements control location, activation threshold, and p38 docking of ribosomal S6 kinase B (RSKB). J Biol Chem 276:5892-5899.
56. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R, Cancer Genome Project. 2004. Mechanism of activation of the Raf-ERK signaling pathway by oncogenic mutations of B-Raf. Cell 116:855-867.
57. Wang ZX, Zhou B, Wang QM, Zhang ZY. 2002. A kinetic approach for the study of protein phosphatase-catalyzed regulation of protein kinase activity. Biochemistry 41:7849-7857.
58. Wegener D, Wirsching F, Riester D, Schwienhorst A. 2003. A fluorogenic histone deacetylase assay well suited for high-throughput activity screening. Chem Biol 10:61-68.
59. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
60. Wu J, Janknecht R. 2002. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem 277:42669-42679.
61. Yang SH, Yates PR, Whitmarsh AJ, Davis RJ, Sharrocks AD. 1998. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol 18:710-720.
62. Yang SH, Shore P, Willingham N, Lakey JH, Sharrocks AD. 1999. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1. EMBO J 18:5666-5674.
63. Yang SH, Vickers E, Brehm A, Kouzarides T, Sharrocks AD. 2001. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol Cell Biol 21:2802-2814.
64. Yang SH, Bumpass DC, Perkins ND, Sharrocks AD. 2002. The ETS domain transcription factor Elk-1 contains a novel class of repression domain. Mol Cell Biol 22:5036-5046.
65. Yang SH, Jaffray E, Hay RT, Sharrocks AD. 2003. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol Cell 12:63-74.
66. Zhang ZY, Zhou B, Xie L. 2002. Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol Ther 93:307-317.
67. Zhao Y, Bjorbaek C, Weremowicz S, Morton CC, Moller DE. 1995. RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 15:4353-4363.
68. Zhong S, Jansen C, She QB, Goto H, Inagaki M, Bode AM, Ma WY, Dong Z. 2001. Ultraviolet B-induced phosphorylation of histone H3 at serine 28 is mediated by MSK1. J Biol Chem 276:33213-33219.